本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Relmada Therapeutics, Inc.

4.14
+0.19004.81%
成交量:50.46万
成交额:205.56万
市值:3.04亿
市盈率:-1.89
高:4.32
开:3.93
低:3.90
收:3.95
52周最高:4.34
52周最低:0.2404
股本:7,333.36万
流通股本:6,314.92万
量比:0.53
换手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):-2.1880
每股收益(LYR):-2.6515
净资产收益率:-175.12%
总资产收益率:-95.67%
市净率:19.04
市盈率(LYR):-1.56

数据加载中...

2023/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/17

重要事件披露

8-K - Current report
2023/01/09

重要事件披露

8-K - Current report
2023/01/05

重要事件披露

8-K - Current report
2022/12/28

重要事件披露

8-K - Current report
2022/12/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/07

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals